Table 5.

In-hospital mortality among patients with lactate <1.33 mmol/L and patients with lactate >1.33 mmol/L stratified by different patient subgroups.

Patient subgroup		Lactate <1.33 mmol/L	Lactate ≥ 1.33 mmol/L	p-value
Age	<50	1 (1.0)	7 (3.6)	0.27
	≥50	6 (2.3)	46 (4.6)	0.09
Sex	Male	4 (2.2)	29 (4.5)	0.18
	Female	3 (1.6)	24 (4.4)	0.08
Diabetes	Yes	4 (5.3)	19 (5.0)	0.92
	No	3 (1.0)	34 (4.2)	0.01
HTN	Yes	5 (2.7)	30 (4.3)	0.33
	No	2 (1.1)	23 (4.7)	0.03
Dyslipidemia	Yes	3 (3.1)	9 (2.3)	0.65
	No	4 (1.5)	43 (5.4)	0.008
Immunocompromised	Yes	0 (0.0)	11 (7.6)	0.45
	No	7 (2.0)	41 (4.0)	0.08
CAD	Yes	2 (2.7)	20 (6.3)	0.23
	No	5 (1.7)	33 (3.8)	0.09
COPD	Yes	1 (3.4)	8 (5.8)	0.61
	No	6 (1.8)	45 (4.3)	0.04
CHF	Yes	0 (0.0)	25 (13.2)	0.07
	No	7 (2.1)	28 (2.8)	0.46
Sepsis	Yes	3 (2.4)	34 (5.9)	0.11
	No	3 (1.4)	14 (3.2)	0.17
Vasopressors	Yes	1 (11.1)	9 (15.3)	0.74
	No	6 (1.7)	44 (3.9)	0.046